Introduction
Depression is the most frequent psychiatric disorder in patients with epileptic seizures (ES) and has been increasingly recognized as a significant factor in the quality of life, morbidity, and mortality of epilepsy patients. 1, 2 The prevalence of depression in patients with ES has been estimated to be 3-9% among those with wellcontrolled seizures 1 and 20-55% in individuals with refractory epilepsy. 3 Additionally, some studies suggest the prevalence of depression varies by seizure type with complex partial seizures, particularly with left temporal lobe onset, having higher rates. 4, 5 The relationship between depression and epilepsy appears to be complex and bidirectional, with potential commonalities in treatments, neurotransmitter abnormalities, and neuropathological processes. 6 Depression is also common among patients with psychogenic nonepileptic seizures (PNES), typically at a higher rate than in patients with epileptic seizures. 7 The estimated prevalence in PNES is 20-40% in those who are referred to epilepsy centers 8, 9 and as high as 85% in some samples.
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With regards to gender differences in these populations, Holmes et al. 11 demonstrated that relative to male PNES patients, men with ES and women with either ES or PNES exhibited significantly higher elevations on multiple scales of a psychopathology measure (MMPI), including depression. Interestingly, both left and right seizure onset groups have produced significantly elevated depression scores on the same measure.
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Depression is a multidimensional condition encompassing affective, physiological, and cognitive symptoms. Although depression's high comorbidity with both ES and PNES has been established, few studies have addressed whether the types of depressive symptoms experienced by these groups differ. Some preliminary studies have suggested that PNES patients are more likely to endorse the physiological symptoms of depression. [13] [14] [15] The present study addressed this issue by comparing the selfreported depressive symptoms of patients with ES and PNES on an inpatient epilepsy monitoring unit. In addition, gender differences within and between groups were examined. Finally, differences in self-reported depressive symptoms were also compared between several subgroups with ES.
Methods

Participants
The present research retrospectively examined the selfreported depressive symptomatology of patients (n = 60 ES and Depression is a multidimensional condition encompassing affective, physiological, and cognitive symptoms. Although depression's high comorbidity with both epileptic and psychogenic nonepileptic seizures (ES and PNES) has been established, few studies have addressed whether the types of depressive symptoms experienced differ by seizure type (ES and PNES). This study compared the self-reported depressive symptomatology of patients (n = 60 ES and 59 PNES) who underwent video-EEG monitoring and completed self-reported objective measures of psychopathology (PAI and BDI-II). Differences in depressive symptoms were also compared by gender and among several subgroups with ES. Results revealed the PNES group, particularly PNES females, endorsed a significantly higher level of physiological symptoms of depression as measured by the PAI DEP-P subscale than the ES group; the BDI-II did not differ between groups. These findings have potential clinical implications for the identification and management of depressive symptoms among these patient groups.
ß . The ES subgroups examined included temporal (n = 23) vs. extra-temporal (n = 6), right onset (n = 16) vs. left onset (n = 8), and partial (n = 29) vs. generalized onset (n = 8). St. Joseph's Hospital's Institutional Review Board approved the inclusion of all patients' data in the study.
Measures
The Beck Depression Inventory-Second Edition (BDI-II), a reliable and valid self-report measure consisting of 21 items, has been commonly used to assess depressive symptoms in both research and clinical settings. It assesses the severity of recent depressive symptoms by evaluating DSM-IV criteria for depressive disorders. 16 The Personality Assessment Inventory (PAI) 17 is a 344 item selfreport measure of psychiatric symptomatology. The PAI yields a DEP clinical scale which measures features common to the syndrome of depression and three subscales reflecting the major constellations of depressive symptomatology: cognitive symptoms such as feelings of worthlessness and concentration difficulties (DEP-C); affective symptoms such as sadness or anhedonia (DEP-A); and physiological symptoms such as fatigue and disturbances in sleep, appetite, and libido (DEP-P).
Results
Comparisons between ES and PNES groups
The ES and PNES groups did not differ significantly on any of the demographic variables. Omnibus multiple analysis of variance (MANOVA) yielded statistically significant [F(13,105) = 3.57, p < 0.01] differences between the self-reported depressive symptoms of the PNES and ES groups. Although their overall levels of depressive symptomatology did not differ, the PNES group endorsed a significantly higher level of physiological symptoms of depression as measured by the PAI DEP-P subscale than the ES group (see Table 1 ; [F(1,117) = 5.76, p < 0.05]). The PNES group's DEP-P mean score was above average relative to the normative sample; a T-score of 61 is at the 86th percentile.
Gender differences were also examined. Comparison of the selfreported depressive symptoms between PNES females and males yielded a statistically significant difference (omnibus MANOVA [F(5,53) = 2.77, p < 0.01]). Relative to males with PNES, females with PNES reported a significantly higher level of physiological symptoms of depression as measured by the PAI DEP-P subscale [F(1,57) = 11.35, p < 0.01]). Gender comparisons among the ES group yielded a trend for females to endorse higher levels of physiological depression than males [F(1,58) = 3.80, p = 0.05].
Comparison of the female patients with ES vs. PNES yielded a trend for the PNES females to endorse higher levels of physiological depression (DEP-P) ( Table 2 ). Among the men in the study, there were no significant differences in self-reported depressive symptoms between those with ES vs. PNES.
Comparisons between ES subgroups
Analyses yielded no significant differences between the ES subgroups (i.e., temporal vs. extra-temporal, right onset verse left onset, or partial onset vs. generalized onset) ( Table 3 ). The aforementioned results should be taken in the context of disproportionate numbers in each group, with some groups having limited sample size.
Discussion
Although the overall levels of self-reported depressive symptoms did not differ between the ES and PNES groups, there were significant differences in the types of depressive symptoms endorsed by the two groups. Gender comparisons suggested this finding was largely attributable to the significantly higher rate of physiological symptoms of depression among the female patients with PNES. Relative to normative data, the self-reported level of overall depressive symptoms was at the upper end of normal limits for both patient groups; and when the different dimensions of depressive symptoms were considered, the PNES group endorsed a mildly elevated rate of physiological symptoms. Female participants with PNES had an average level of depression symptom endorsement that approached clinical levels. Furthermore, treating the scores as categorical (elevated or not; T 65) rather than continuous did not yield significantly different findings between groups except in the case of PNES females; 50% of PNES females had elevations on the physiological symptoms of depression Table 1 Mean scores on measures of self-reported depressive symptoms for ES and PNES patients. subscale compared to only 18% of PNES males. Elevations on these self-report measures are not equivalent to a diagnosis of major depression, but are useful in identifying patients in need of further psychiatric evaluation. 18 What types of depressive symptoms patients are experiencing can influence treatment selection and has clinical implications for the identification of depression among patients in an EMU or epilepsy clinic setting. Our results suggest patients with PNES may be at increased risk of being under diagnosed with depression. Given their propensity to express their emotional distress as somatic symptoms, they may not recognize their physiological symptoms as related to depression and might be more likely to present for medical than psychiatric care. Furthermore, some of the brief screening measures designed to screen for depression among epilepsy patients (e.g., Neurological Disorders Depression Inventory for Epilepsy; NDDI-E 19 ;
do not include more physiological symptoms in efforts to minimize the potential impact of AED side effects. Our findings highlight the importance of multidimensional assessment of depressive symptoms and inquiring about vegetative as well as affective aspects of the condition in settings where PNES as well as ES patients are present. Untreated depression presents an economic burden (increased disability and utilization of medical services), negatively impacts patients' quality of life, and may trigger expression of conversion disorder among those patients prone to PNES. 20, 21 No significant differences in depressive symptoms were observed when comparing the different epilepsy subgroups. The present study's ability to explore the differences in depressive symptoms among the ES subgroups was limited by the small sample sizes in some groups and these findings should be explored with a larger sample size.
Given this was archival data the actual rate of diagnosed depression and identification of persons in treatment for depression was not available and should be heavily considered in future research.
The present study was also limited to examination of only depressive symptoms; we plan to examine differences in other forms of psychopathology (e.g., anxiety, PTSD, somatization) among EMU patients in future research.
